3,605
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Synthesis and discovery of the first potent proteolysis targeting chimaera (PROTAC) degrader of AIMP2-DX2 as a lung cancer drug

, , , , , & ORCID Icon show all
Pages 51-66 | Received 05 Aug 2022, Accepted 08 Oct 2022, Published online: 28 Oct 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.